» Articles » PMID: 31293586

IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis

Overview
Journal Front Immunol
Date 2019 Jul 12
PMID 31293586
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

The IL-1 family of cytokines are well-known for their primary role in initiating inflammatory responses both in response to and acting as danger signals. It has long been established that IL-1 is capable of simultaneously regulating inflammation and angiogenesis, indeed one of IL-1's earliest names was haemopoeitn-1 due to its pro-angiogenic effects. Other IL-1 family cytokines are also known to have roles in mediating angiogenesis, either directly or indirectly via induction of proangiogenic factors such as VEGF. Of note, some of these family members appear to have directly opposing effects in different tissues and pathologies. Here we will review what is known about how the various IL-1 family members regulate vascular permeability and angiogenic function in a range of different tissues, and describe some of the mechanisms employed to achieve these effects.

Citing Articles

ARNT-dependent HIF-2α signaling protects cardiac microvascular barrier integrity and heart function post-myocardial infarction.

Ullah K, Ai L, Li Y, Liu L, Zhang Q, Pan K Commun Biol. 2025; 8(1):440.

PMID: 40089572 DOI: 10.1038/s42003-025-07753-1.


Contribution of tumor microenvironment (TME) to tumor apoptosis, angiogenesis, metastasis, and drug resistance.

Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M Med Oncol. 2025; 42(4):108.

PMID: 40087196 DOI: 10.1007/s12032-025-02675-8.


Expression of angiogenic factors in the mammalian senescent cell sustaining Trichinella spp. muscle larvae.

Dabrowska M, Kepczynska A, Gozdzik K, Nowak N, Uram L, Skoneczny M Histochem Cell Biol. 2025; 163(1):33.

PMID: 40029443 DOI: 10.1007/s00418-025-02363-8.


Harnessing the Power of Machine Learning Guided Discovery of NLRP3 Inhibitors Towards the Effective Treatment of Rheumatoid Arthritis.

Ilyas S, Manan A, Park C, Jo H, Lee D Cells. 2025; 14(1).

PMID: 39791728 PMC: 11719798. DOI: 10.3390/cells14010027.


Differential expression of plasma proteins and pathway enrichments in pediatric diabetic ketoacidosis.

Spagnolo P, Cela E, Patel M, Tweddell D, Daley M, Clarson C Mol Med. 2025; 31(1):4.

PMID: 39773407 PMC: 11707870. DOI: 10.1186/s10020-024-01056-7.


References
1.
Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y . Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. J Mol Cell Cardiol. 1999; 31(3):607-17. DOI: 10.1006/jmcc.1998.0895. View

2.
Garcia de Yebenes E, Ho A, Damani T, Fillit H, Blum M . Regulation of the heparan sulfate proteoglycan, perlecan, by injury and interleukin-1alpha. J Neurochem. 1999; 73(2):812-20. DOI: 10.1046/j.1471-4159.1999.0730812.x. View

3.
Gracie J, Forsey R, Chan W, Gilmour A, Leung B, Greer M . A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest. 1999; 104(10):1393-401. PMC: 409841. DOI: 10.1172/JCI7317. View

4.
Cao R, Farnebo J, Kurimoto M, Cao Y . Interleukin-18 acts as an angiogenesis and tumor suppressor. FASEB J. 1999; 13(15):2195-202. DOI: 10.1096/fasebj.13.15.2195. View

5.
Thurston G, Rudge J, Ioffe E, Zhou H, Ross L, Croll S . Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. 2000; 6(4):460-3. DOI: 10.1038/74725. View